Investment Rating - The investment rating for the company is "Accumulate" [11][18]. Core Views - The company's domestic business is stable, while overseas operations have been a drag on performance. However, there are signs of improvement in overseas business in Q1 2025, supported by foreign exchange gains that enhance profits [2][11]. Financial Summary - Revenue for 2024 is projected at 30.36 billion CNY, a year-on-year increase of 4.14%. The net profit attributable to the parent company is expected to be -3.10 billion CNY, a decline of 392.99% year-on-year. For Q1 2025, revenue is estimated at 6.90 billion CNY, a decrease of 7.82% year-on-year, while net profit is expected to be 0.41 billion CNY, an increase of 40.24% year-on-year [4][11]. - The earnings per share (EPS) for 2025 is projected to be 0.50 CNY, with estimates of 0.55 CNY and 0.59 CNY for 2026 and 2027 respectively. The target price is set at 8.0 CNY, based on a price-to-earnings (PE) ratio of 16 times, which is above the industry average [11][13]. - The company has a total market capitalization of 2,547 million CNY and a total equity of 2,535 million CNY, with a net asset value per share of 6.87 CNY [6][7]. Business Performance - In 2024, the domestic business showed a year-on-year revenue growth of 10%, while the overseas business, particularly the IRO brand, faced challenges that affected overall revenue growth. The gross profit margin decreased by 0.4 percentage points, and various expenses increased, leading to a significant rise in asset impairment losses [11]. - The company operates several brands, with revenue contributions from ELLASSAY, Laurel, SP, IRO, and EH showing mixed results. The online sales channel grew by 32.42%, while offline sales saw a slight decline [11]. Market Data - The stock price has fluctuated between 5.83 CNY and 8.81 CNY over the past 52 weeks, with a current price of 6.90 CNY [6][10]. - The company has a net debt ratio of -16.01%, indicating a strong balance sheet position [7].